Research Paper Volume 15, Issue 21 pp 12275—12295
Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma
Figure 6. Construction of m5c-related signature. (A, B) Identification of prognostic genes and the coefficients constructed using the LASSO method. (C, D) Comparing survival in high- and low-risk subgroups by drawing K-M survival curves in the total TCGA cohort, training group (C) and validation group (D). (E) The ROC curves of patients with glioma in training group (F) and validation group.